EMA Authorised: Clopidogrel HCS (clopidogrel (as hydrochloride)) — HCS bvba

View source ↗

Summary

The EMA authorised Clopidogrel HCS (clopidogrel hydrochloride) for several cardiovascular indications including peripheral vascular diseases, acute coronary syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Peripheral Vascular Diseases
• Stroke

Drugs mentioned

• Clopidogrel HCS (clopidogrel (as hydrochloride))

Snippet

Status: Authorised. Therapeutic area: Peripheral Vascular Diseases;Acute Coronary Syndrome;Myocardial Infarction;Stroke. MAH: HCS bvba. Decision date: 03/05/2018